On December 4th, the latest research results of Professor Bo Han's research team. KIF15-mediated stabilization of AR and AR-V7 contributes to enzalutamide resistance in prostate cancer was published online in Canser Research, an internationally authoritative oncology journal (SCI Journal of the Chinese Academy of Sciences, Division 1 journal, nearly five years of effect factor 9.883). The first author is Lin Gao, Ph.D. student, Professor Han Bo and Professor Xuesen Dong of Columbia University in Canada are co-authors, and Shandong University School of Basic Medical Sciences is the first communication author.

Professor Bo Han's team has been engaged in the study of the clinical-pathological histology of prostate cancer and the development and evolution of prostate cancer. Over the past three years, 16 articles have been published in SCI-included journals such as Oncogene. Professor Bo Han's research on the molecular pathological mechanism of prostate cancer is also one of the important scientific research directions of the Department of Pathology, which has been funded by several projects of the National Natural Science Foundation of China

The paper link: https://cancerres.aacrjournals.org/content/early/2020/12/04/0008-5472.CAN-20-1965